Bioinformatics Clinical Development In-Vivo RNA 
Drug Discovery World
NOVEMBER 13, 2023
On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.
Drug Discovery World
NOVEMBER 30, 2023
GSK has developed high-throughput mammalian and E. DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023. The company’s goal is to accelerate functional characterisation and shortenoptimisation time in antibody discovery and t-cell workflows.
Expert insights. Personalized for you.
59 
Let's personalize your content